Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma
Open Access
- 21 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 6 (1), 1-11
- https://doi.org/10.1038/s41392-020-00388-0
Abstract
Mucoepidermoid carcinoma (MEC) is the most common type of salivary gland cancers and patients with advanced, metastatic, and recurrent MECs have limited therapeutic options and poor treatment outcomes. MEC is commonly associated with a chromosomal translocation t(11;19) (q14-21;p12-13) that encodes the CRTC1-MAML2 oncogenic fusion. The CRTC1-MAML2 fusion is required for MEC growth in part through inducing autocrine AREG-EGFR signaling. Growing evidence suggests that MEC malignancy is maintained by cancer stem-like cells. In this study, we aimed to determine critical signaling for maintaining MEC stem-like cells and the effect of combined targeting of stem cell signaling and CRTC1-MAML2-induced EGFR signaling on blocking MEC growth. First, we evaluated the significance of Notch signaling in regulating MEC stem-like cells. Aberrantly activated Notch signaling was detected in human fusion-positive MEC cells. The inhibition of Notch signaling with genetic or pharmacological inhibitors reduced oncosphere formation and ALDH-bright population in vitro and blocked the growth of MEC xenografts in vivo. Next, we investigated the effect of co-targeting Notch signaling and EGFR signaling, and observed enhanced inhibition on MEC growth in vivo. Collectively, this study identified a critical role of Notch signaling in maintaining MEC stem-like cells and tumor growth, and revealed a novel approach of co-targeting Notch and EGFR signaling as a potential effective anti-MEC treatment.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (R01DE023641)
This publication has 57 references indexed in Scilit:
- CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cellsOncogene, 2018
- Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequencyScience Translational Medicine, 2017
- Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cellsBMC Cancer, 2015
- EGFR Blockade Enriches for Lung Cancer Stem–like Cells through Notch3-Dependent SignalingCancer Research, 2014
- Therapeutic modulation of Notch signalling — are we there yet?Nature Reviews Drug Discovery, 2014
- Salivary Gland Cancers: Biology and Molecular Targets for TherapyCurrent Oncology Reports, 2012
- Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNature Reviews Cancer, 2010
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Notch and cancer: a double-edged swordCellular and Molecular Life Sciences, 2007
- Mect1-Maml2 Fusion Oncogene Linked to the Aberrant Activation of Cyclic AMP/CREB Regulated GenesCancer Research, 2005